Assess the Current Market Trends within Insulin Delivery Systems.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c37893) has announced the addition of New Developments in Insulin insulin, hormone secreted by the β cells of the islets of Langerhans, specific groups of cells in the pancreas. Insufficiency of insulin in the body results in diabetes. Insulin was one of the first products to be manufactured using genetic engineering. Delivery Systems (2006) to their offering Insulin, a hormone hormone, secretory substance carried from one gland or organ of the body via the bloodstream to more or less specific tissues, where it exerts some influence upon the metabolism of the target tissue. secreted by the beta cells beta cells, n See cells, beta. of the pancreas pancreas (păn`krēəs), glandular organ that secretes digestive enzymes and hormones. In humans, the pancreas is a yellowish organ about 7 in. (17.8 cm) long and 1.5 in. (3.8 cm) wide. , is responsible for regulating reg·u·late tr.v. reg·u·lat·ed, reg·u·lat·ing, reg·u·lates 1. To control or direct according to rule, principle, or law. 2. the level of sugar in human body. The insufficient or nil production of this vital hormone is the main cause of diabetes. People suffering from diabetes have to undergo insulin therapy, so that they can combat and prevent such problems. Immense research and development is going on in the insulin delivery technology market today, so that new avenues can be explored for the cure and control of diabetes. Although there are a few effective methods for treating diabetes, such as use of syringe syringe /sy·ringe/ (si-rinj´) (sir´inj) an instrument for injecting liquids into or withdrawing them from any vessel or cavity. for injecting insulin, but they are extremely painful for the patient. The syringe will soon be outdated out·dat·ed adj. Out-of-date; old-fashioned. outdated Adjective old-fashioned or obsolete Adj. 1. and replaced by various emerging technological innovations being developed in the industry. Various alternative insulin delivery methods such as oral insulin spray, transdermal patch transdermal patch: see skin patch. and oral insulin pill are being developed by scientists, with the aid provided by public & private sectors. As per our research experts, the global insulin drug market exceeded $23 million in the year 2004 and is anticipated to reach $30 billion towards the end of the year 2014. Insulin and TZDs make up for a sizeable share of seventy-five percent of the overall anti-diabetic market. REPORT HIGHLIGHTS --Evaluation of current market trends. --Discussion about the leading edge technologies. --Scope of the major insulin delivery systems all over the world. --Profile discussion of key players in this sector. --Analysis of various challenges and opportunities before the industry. --Classification of various stimulating factors. REPORT FEATURES The market research report "New Developments in Insulin Delivery Systems (2006)" provides a comprehensive discussion about diabetes, including the symptoms and diagnosis of the disease, plus an in-depth in-depth adj. Detailed; thorough: an in-depth study. in-depth Adjective detailed or thorough: an in-depth analysis analysis of the drug market of this disease. The latest developments taking place in the insulin delivery systems research and development market, market projections for this sector are also covered in this report. The report is an extremely valuable document for both the investors as well as businesses.
Topics Covered
1. Diabetes Disease Indicator
2. Global Market Analysis
2.1 Overview of Global Diabetes Drug Market, 2008
2.2 Global Insulin Supply
2.3 Key Trends of Diabetes Markets Worldwide
2.4 Global Diabetes Drug Demand Analysis
2.4.1 Demand Analysis
2.5 Diabetes Market Growth by Products, 2008
3. Insulin Delivery Market
3.1 Market Size And Growth Rate
3.1.1 USA
3.1.2 South and Central America
3.1.3 Western Pacific
3.1.4 Europe
3.1.5 Asia
3.1.6 South-East Asia
3.2 Comparative Study of Traditional and Non-Traditional Therapeutic
Market
3.2.1 Insulin Syringes
3.2.2 Insulin Pens
3.2.3 Insulin Jet Injectors
3.2.4 Oral Drug Delivery
3.2.5 Pump Therapy
3.3 Non-Injectable Insulin Market
3.3.1 Market Overview
3.3.2 Worldwide Products Sales
3.4 Market Projection: Future Ahead by 2008
4. Treatment of Diabetes
4.1 Gene Therapy
4.2 Pump Therapy
4.3 Xenotransplantion
4.4 Recombinant Human Insulin-like Growth Factor-I (rhIGF-I)
4.5 Islet Cell Transplant
4.6 Drugs for Type 2 Diabetes
4.6.1 Dual PPARy/ Agonists
4.6.2 Orlistat
4.6.3 Insulin Secretagogues
4.7 Therapy for Type 2 Diabetes
4.7.1 Increase Insulin Sensitivity
4.7.2 Increase Circulating Insulin
4.7.3 Exogenous Insulin
4.8 Diabetes Monitoring Devices
4.8.1 Pain Free Glucose Tests
4.8.2 Continuous Monitoring Device
5. Recent Trends and Developments
6. Key Drivers
7. Outlook
List of Tables
List of Figures
Companies Mentioned
-- Eli Lilly and Company - Novo Nordisk A/S - Sanofi-Aventis -
GlaxoSmithKline plc - Amylin Pharmaceuticals, Inc.
For more information visit http://www.researchandmarkets.com/reports/c37893 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion